PLX – protalix biotherapeutics, inc. (de) (US:NASDAQ)
Stock Stats
News
12/12
11:04 pm
plx
Low
Protalix BioTherapeutics, Inc. (NYSE: PLX) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
12/9
06:48 am
plx
Low
Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce Validation of Variation Submission by European Medicines Agency for pegunigalsidase alfa [Yahoo! Finance]
12/9
06:30 am
plx
Low
Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce Validation of Variation Submission by European Medicines Agency for pegunigalsidase alfa
12/9
06:30 am
plx
Low
Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce Validation of Variation Submission by European Medicines Agency for pegunigalsidase alfa
11/19
12:09 am
plx
Low
Protalix BioTherapeutics, Inc. (NYSE: PLX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
11/14/2024
06:50 am
plx
13.7%
MISS
8/14/2024
06:50 am
plx
-10.6%
MISS
11/14
07:04 am
plx
High
Form 10-Q Protalix BioTherapeutics For: Sep 30
11/14
06:58 am
plx
High
Form 8-K Protalix BioTherapeutics For: Nov 14
11/5
05:00 pm
plx
Medium
Form 4/A Protalix BioTherapeutics For: Sep 23 Filed by: Rubin Eyal
10/25
04:24 pm
plx
Medium
Form SC 13G/A Protalix BioTherapeutics Filed by: WHITEBOX ADVISORS LLC
10/25
08:28 am
plx
Low
Form 8-K Protalix BioTherapeutics For: Oct 25
Show more
Top News Gainers
10/17 Protalix BioTherapeutics Announces Positive 12-Month Interim Data From the BRIDGE Phase III Open Label Switch-over Study of Pegunigalsidase Alfa for the Treatment of Fabry Disease 65.8%
11/18 Protalix BioTherapeutics and Chiesi Farmaceutici Announce Successful pre-BLA Meeting with FDA for Accelerated Approval of pegunigalsidase alfa for the Treatment of Fabry Disease in the United States 35.8%
6/6 Protalix BioTherapeutics and Chiesi Farmaceutici S.p.A to Apply for Accelerated Approval of pegunigalsidase alfa for the Treatment of Fabry Disease in the United States 35.2%
4/13 Form 4 Protalix BioTherapeutics For: Apr 07 Filed by: Schwartz Aharon 21.2%
1/3 Form 3 Protalix BioTherapeutics For: Jan 01 Filed by: Melincoff Gwen A 18.2%
3/23 Form SC 13G Protalix BioTherapeutics Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC 8.3%
4/17 Form S-3 Protalix BioTherapeutics 7.7%
11/27 Protalix BioTherapeutics Hosting Key Opinion Leader Meeting on PRX-102 Drug Candidate for the Treatment of Fabry Disease 7.5%
3/5 Protalix BioTherapeutics to Hold Fourth Quarter and Full-Year 2019 Financial and Business Results Conference Call on March 12, 2020 7.3%
8/22 Protalix BioTherapeutics Focuses on Evaluating and Pursuing Alternatives to Maximize Shareholder Value through Refinancing & Strategic Partnerships 6.2%
Top News Decliners
8/8 Form 8-K Protalix BioTherapeutics For: Aug 08 -40.2%
4/30 Form EFFECT Protalix BioTherapeutics -17.2%
2/6 Form 8-K Protalix BioTherapeutics For: Feb 06 -9.0%
3/12 Form 10-K Protalix BioTherapeutics For: Dec 31 -8.4%
3/12 Protalix BioTherapeutics Reports Fourth Quarter and Full Year 2019 Financial and Business Results -7.4%
10/4 Form PRE 14A Protalix BioTherapeutics For: Dec 09 -7.2%
5/6 Form 8-K Protalix BioTherapeutics For: May 06 -6.9%
7/29 Protalix BioTherapeutics Appoints Eyal Rubin as its New Senior Vice President and Chief Financial Officer -6.0%
8/13 Shlomo Yanai Resigns as Chairman of the Board of Protalix BioTherapeutics -5.7%
8/30 Protalix BioTherapeutics Receives Listing Deficiency Letter from NYSE American -5.7%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3